12 Best Genomic Stocks to Buy Now
In this article, we present to you the 12 best genomic stocks to buy now according to hedge funds. If you’re in a hurry you can skip ahead to the...
Posts Tagged ‘Biomarin Pharmaceutical Inc (BMRN)’
12 Best Large Biotech Stocks to Buy Now
In this article, we are going to present to you the 12 Best Large Biotech Stocks to Buy Now. Click to skip ahead and jump to the 5 Best Large Biotech...
Hedge Fund and Insider Trading News: Steven A Cohen, Crispin Odey, Ray Dalio, Warren Buffett, Adrigo Hedge, iMedia Brands Inc (IMBI), Estee Lauder Companies Inc (EL), and More
Bridgewater’s Risk-Parity Shift Jolts a $400 Billion Quant Trade (Bloomberg) The $400 billion corner of quant investing known as risk parity has a history...
Catalyst Pharmaceuticals Inc (CPRX) Isn’t Out Of The Woods With Firdapse Just Yet
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) just announced that it is carrying forward with a special protocol assessment (SPA) for its lead asset, Firdapse...
10 Most Successful Innovative Companies in The World in 2016
Which are the most successful innovative companies in the world in 2016? Bringing something new to the table is something that seems to be difficult these...
A Look At The Science Behind BioMarin Pharmaceutical Inc. (BMRN)’s Next Pivotal Candidate
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) just put out an update relating to its lead achondroplasia asset, Vosoritide, and the company is up a couple...
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California. Prior to founding Blue Jay...
BioMarin Pharmaceutical Inc. (BMRN)’s Setback Isn’t Really A Setback
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) just announced that the FDA has delayed its PDUFA for the companies lead Batten Disease candidate, meaning...
Thursday’s Top Trending Tickers: MSFT, VOD, LB, BMRN, GLW
The U.S stock market is green across the board as positive reigns ahead of crucial jobs data to be announced tomorrow. Some of the stocks that investors...
Why Traders Are Buzzing About MGM, Apple, and Three Other Companies Today
Although crude futures are well in the green, the three indexes have opened in the red on Friday. The Dow and S&P 500 are off by 0.2% while the NASDAQ...
Mariner Investment’s Top Healthcare Picks
Among some 800 hedge funds we track at Insider Monkey, we seldom come across funds that specialize in investing in a particular sector or have a penchant...
Palo Alto’s Top Picks for This Year Following Impressive 2015 Returns
William Leland Edwards‘ Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management. According to our calculations...
Top Stock Picks of Multi-Billion Dollar, Healthcare-Focused Fund Palo Alto Investors
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States...
New Additions Highlight Kyle Bass’ Top Stock Picks for Q4
Kyle Bass of Hayman Advisors is one investment manager with great cachet, which includes having a chapter dedicated to him in Michael Lewis’ post...
BioMarin Pharmaceutical Inc. (BMRN) Surges But Is It A Good Stock To Buy Now?
Is BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) a good stock to buy now? Shares of the company are surging today after the pharmaceutical firm revealed...
Endo International plc (ENDP), BioMarin Pharmaceutical Inc. (BMRN): Visium Picks Returned 13% but Net Returns Were Only 5% – Here’s Why
The broad portfolio of Jacob Gottlieb’s Visium Asset Management enjoyed a very strong quarter, with the weighted average returns of its 817 reported...
Billionaire John Griffin’s Five Picks That Killed the Market This Quarter
John Griffin’s Blue Ridge Capital had a great start to the year, as its 45 long positions in stocks with a market cap above $1.0 billion returned 6....
Era Group Inc (ERA), BioMarin Pharmaceutical Inc. (BMRN), & Assured Guaranty Ltd. (AGO) Among Stocks Amici Capital Is Bullish on
Paul Orlin‘s Amici Capital has increased its exposure to Era Group Inc (NYSE:ERA), as a new filing with the Securities and Exchange Commission...
Palo Alto Rejoicing at ABIOMED, Inc. (ABMD)’s 18% Spike
ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday’s intraday trading to eventually close at 18% in the green at $72.48. The rise came...
BioMarin Pharmaceutical Inc. (BMRN) and Other Top New Picks of Healthcare-Focused Visium Asset Management
Jacob Gottlieb‘s Visium Asset Management has recently revealed its equity positions as of the end of the fourth quarter in a 13F filing with the...
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio. One of the companies involved...
Should You Buy Regeneron Pharmaceuticals Inc (REGN)?
Is Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a good investment? If you were to ask many investors, hedge funds are viewed as delayed, outdated investment...
AstraZeneca plc (ADR) (AZN), Bristol-Myers Squibb Co (BMY), BioMarin Pharmaceutical Inc. (BMRN): Three PDUFA Dates That Will Kick Off 2014
The phrase “PDUFA date” is thrown around frequently when discussing biotech and pharma companies. PDUFA stands for the Prescription Drug User...
What Hedge Funds Think About Vertex Pharmaceuticals Incorporated (VRTX)
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a buy? In the 21st century investor’s toolkit, there are tons of metrics market participants can...
Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use...
Do Hedge Funds and Insiders Love Alexion Pharmaceuticals, Inc. (ALXN)?
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) investors are standing pat. In the 21st century investor’s toolkit, there are dozens of indicators investors...
Hedge Funds Are Crazy About BioMarin Pharmaceutical Inc. (BMRN)
Should you be crazy about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)? In the financial world, there are dozens of gauges shareholders can use to analyze...
Is Illumina, Inc. (ILMN) Going to Burn These Hedge Funds?
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times. Although there are more...
Incyte Corporation (INCY), BioMarin Pharmaceutical Inc. (BMRN): Two Biotech Stocks That Could Be on Novartis AG (ADR) (NVS)’s Buyout Radar
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is really beginning to heat up, and it’s offering investors...
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases
There are few times when your doctor or physician will utter the phrase, “I don’t know” to a patient, but when you’re dealing...
Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), BioMarin Pharmaceutical Inc. (BMRN): Orphan Drug Makers – Robust Investment Opportunities
The US pharmaceutical industry has been revolutionized by the emerging biotech companies which have discovered new ways to cure even the rarest of diseases...
Alexion Pharmaceuticals, Inc. (ALXN), Eli Lilly & Co. (LLY): Five Drugmakers With a Lot on the Line
You may or may not have heard, but it’s earnings season again. Contrary to popular belief, earnings season does actually take a break for a few...
Exploding Pipeline Makes BioMarin Pharmaceutical Inc. (BMRN) Attractive Takeover Target
The Orphan Drug pipeline of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has been growing so rapidly that the company has been the object of many takeover...
LinkedIn Corp (LNKD), BioMarin Pharmaceutical Inc. (BMRN), ArcelorMittal (ADR) (MT): Don’t Miss These Three Companies With High Earnings-Per-Share Forecasts
Earnings per share, or EPS, is an important metric for investors performs a lot of functions: It helps suggest potential profits on individual shares...
Wells Fargo & Co (WFC), Baxter International Inc. (BAX): Obamacare-Inspired Investment Opportunities
Love it or hate it, the Patient Protection and Affordable Care Act — commonly referred to as Obamacare — changes the health care landscape...
Dendreon Corporation (DNDN), Johnson & Johnson (JNJ), Medivation Inc (MDVN): The Most Expensive Drugs in the World
The prescription-drug market currently generates a whopping $950 billion in annual sales, and that figure is likely to grow to $1.2 trillion by 2016....
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): What Makes a Good Orphan Drug Investment?
Orphan drug companies are an exciting new class in the healthcare sector — with good and bad investment opportunities — let’s look at...
Highlights from the Goldman Sachs Group Inc (GS) Healthcare Conference
Goldman Sachs Group Inc (NYSE:GS) recently hosted its 34th Annual Global Healthcare Conference on June 11 – 13 in Rancho Palos Verdes, CA. Healthcare...
Clovis Oncology Inc (CLVS), Synta Pharmaceuticals Corp. (SNTA): Post-ASCO Movers – Are Any a Buy?
Late last year, Clovis Oncology Inc (NASDAQ:CLVS) saw its share price cut in half, to $11.50, after reporting that its Phase 3 drug CO-101 failed to show...
Clovis Oncology Inc (CLVS): Double Data, Double Stock Price
Plenty of data was presented at the American Society for Clinical Oncology meeting over the weekend, causing the first set of ASCO pops, but Clovis Oncology...
Hedge Funds Are Selling BioMarin Pharmaceutical Inc. (BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was in 22 hedge funds’ portfolio at the end of the first quarter of 2013. BMRN has experienced a decrease...
Alexion Pharmaceuticals, Inc. (ALXN), Vertex Pharmaceuticals Incorporated (VRTX): Orphan Drug Biotechs Do It Best
There are many biotech stocks to choose from that have long-lasting value. Each one can potentially have huge value, but there is a group of biotech stocks...
Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)’s Fourth Quarter?
Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech...
4 Orphan Drugs Making Waves in 2013: Sanofi SA (ADR) (SNY) and More
Orphan drugs — medications meant for small patient populations with rare, dangerous diseases — can be a rewarding business for biotech firms...
BioMarin Pharmaceutical Inc. (BMRN) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results. But there are still some companies...
BioMarin Pharmaceutical Inc. (BMRN) is a Prime Takeover Target
How many of us as investors want to identify companies that are pioneers in their industry? Is it possible to find commonality across sectors, which factors...
